RAFAEL HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$176.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-04-30 was -$1.14M.
- RAFAEL HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-01-31 was $505.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-10-31 was $457.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-07-31 was -$298.00K, a 165.35% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was -$922.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$146.00K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-04-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$633.00K derived: sum of 2 quarters · filed 2026-06-11 | -$176.00K 10-Q · filed 2026-06-11 | -$474.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2026-01-31 | $505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | $962.00K 10-Q · filed 2026-03-16 | $664.00K derived: sum of 3 quarters · filed 2026-03-16 | $436.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-10-31 | $457.00K 10-Q · filed 2025-12-12 | $159.00K derived: sum of 2 quarters · filed 2025-12-12 | -$69.00K derived: sum of 3 quarters · filed 2026-06-11 | -$347.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-07-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$526.00K derived: sum of 2 quarters · filed 2026-06-11 | -$804.00K derived: sum of 3 quarters · filed 2026-06-11 | -$922.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | -$228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$506.00K derived: sum of 2 quarters · filed 2026-06-11 | -$624.00K 10-Q · filed 2026-06-11 | -$168.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | -$278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$396.00K 10-Q · filed 2026-03-16 | $60.00K derived: sum of 3 quarters · filed 2026-03-16 | |
| 2024-10-31 | -$118.00K 10-Q · filed 2025-12-12 | $338.00K derived: sum of 2 quarters · filed 2025-12-12 | ||
| 2024-07-31 | $456.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$146.00K 10-K · filed 2025-10-29 | ||
| 2024-04-30 | -$602.00K 10-Q · filed 2025-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |